文献速递中医内科中药与中成药合理使用

氧化脂质作为草药治疗心血管疾病的指标:综述

Oxylipins as therapeutic indicators of herbal medicines in cardiovascular diseases: a review.
PubMed 文献 · Front Pharmacol · 2024-12-19

心血管疾病是全球主要死因,氧化脂质是连接炎症和血小板激活等风险因子的新型循环标志物。中草药在心血管疾病辅助治疗中作用重要,但对其调控氧化脂质的机制了解尚少。本综述汇总近期报道,从氧化脂质角度阐明中草药对心血管疾病的调控作用,为治疗靶点研究和治疗新视角提供依据。

要点

  • 氧化脂质是连接炎症、血小板激活等心血管风险因子的关键介质。
  • 中草药辅助治疗心血管疾病可从氧化脂质调控角度阐释机制。
  • 该视角有助于发现中草药治疗靶点并提供心血管治疗新思路。

核心结论

  • 从氧化脂质角度可综合阐明中草药对心血管疾病的调控作用。
  • 该角度有利于进一步研究中草药的治疗靶点并提供治疗新视角。

研究设计与样本

  • 综述,检索并汇总近期关于中草药调控心血管疾病氧化脂质的报道。

主要发现

  • 氧化脂质是心血管疾病的新型循环标志物及连接风险因子的关键介质。
  • 中草药对心血管疾病中氧化脂质的调控作用此前 largely 未知。
  • 近期相关报道增多,有必要从氧化脂质角度全面阐明中草药的调控作用。

临床怎么用

  • 可将氧化脂质作为阐释中草药心血管治疗机制的候选指标。
  • 关注氧化脂质通路有助于探索中草药辅助治疗心血管疾病的新靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Globally, cardiovascular diseases (CVDs) remain the leading cause of death, and their prevention and treatment continue to face major challenges. Oxylipins, as novel circulating markers of cardiovascular disease, are crucial mediators linking cardiovascular risk factors such as inflammation and platelet activation, and they play an important role in unraveling cardiovascular pathogenesis and therapeutic mechanisms. Chinese herbal medicine plays an important role in the adjuvant treatment of cardiovascular diseases, which has predominantly focused on the key pathways of classic lipids, inflammation, and oxidative stress to elucidate the therapeutic mechanisms of cardiovascular diseases. However,The regulatory effect of traditional Chinese medicine on oxylipins in cardiovascular diseases remains largely unknown. With the increasing number of recent reports on the regulation of oxylipins by Chinese herbal medicine in cardiovascular diseases, it is necessary to comprehensively elucidate the regulatory role of Chinese herbal medicine in cardiovascular diseases from the perspective of oxylipins. This approach not only benefits further research on the therapeutic targets of Chinese herbal medicine, but also brings new perspectives to the treatment of cardiovascular diseases.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Li M, He M, Sun M, et al. Oxylipins as therapeutic indicators of herbal medicines in cardiovascular diseases: a review. Front Pharmacol. 2024. PMID: 39749208. doi:10.3389/fphar.2024.1454348

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。